CNS Pharmaceuticals Inc. Company Profile
NASDAQ: CNSPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
CNS Pharmaceuticals at a glance
CNS Pharmaceuticals Inc. (NASDAQ: CNSP) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Houston, TX. CNS Pharmaceuticals is led by Mr. Rami Levin M.B.A. and employs about 8 people. The company's shares have traded publicly since 2019.
At a market capitalization of $7.9 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001729427, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does CNS Pharmaceuticals do?
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of therapies for neurology and oncology diseases in the United States. It develops TPI 287, an investigational chemotherapy agent, which is in Phase II clinical trial for the treatment of glioblastoma, metastatic breast cancer with brain metastases, non-small cell lung cancer, castration-resistant prostate cancer, and neuroblastoma; and Berubicin, an investigational anthracycline chemotherapy agent, which is in Phase II clinical trial for the treatment of glioblastoma and brain tumors. The company was incorporated in 2017 and is headquartered in Houston, Texas.
Business description based on the company's public filings.
Company information
- Legal name
- CNS Pharmaceuticals Inc.
- Ticker
- NASDAQ: CNSP
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Rami Levin M.B.A.
- Employees
- 8
- Headquarters
- 2100 West Loop South, Houston, TX, United States
- Phone
- 800 946 9185
- Website
- cnspharma.com
- IPO year
- 2019
- Market cap
- $7.94M
- SEC CIK
- 0001729427
Companies similar to CNS Pharmaceuticals
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| AZTRAzitra Inc | 0.132 | 0.00% | $8.00M | vs CNSP |
| FBLGFibroBiologics Inc. | 1.11 | -2.63% | $7.72M | vs CNSP |
| APUSApimeds Pharmaceuticals US Inc. | 5.51 | -21.84% | $8.32M | vs CNSP |
| LGVNLongeveron Inc. Class A | 2.37 | -2.87% | $7.56M | vs CNSP |
| SNGXSoligenix Inc. | 0.3466 | -1.95% | $7.54M | vs CNSP |
| CURXCuranex Pharmaceuticals Inc | 4.76 | -0.94% | $7.46M | vs CNSP |
| SKYESkye Bioscience Inc. | 1.68 | +1.82% | $7.44M | vs CNSP |
| TRAWTraws Pharma Inc. | 0.4803 | +0.27% | $7.38M | vs CNSP |